Article

Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: An experimental study based on in vivo brain dialysis

{ "0" : "Department of Internal Medicine II and Hepatogastroenterology, Erasmus University Rotterdam, The Netherlands" , "1" : "Section Pathophysiology of Behaviour, Erasmus University Rotterdam, The Netherlands" , "2" : "Department of Neuro-Anatomy, Erasmus University Rotterdam, The Netherlands" , "3" : "Department of Experimental Surgery, Erasmus University Rotterdam, The Netherlands" , "5" : "Ammonia" , "6" : "Glutamate" , "7" : "Hepatic encephalopathy" , "8" : "Microdialysis"}
Journal of Hepatology (impact factor: 9.26). 02/1994; DOI:10.1016/S0168-8278(05)80462-3 pp.19-26

ABSTRACT Hyperammonemia is thought to be important in the pathogenesis of hepatic encephalopathy. However, the mechanism leading to ammonia toxicity is still not known. Since the metabolism of the most important excitatory neurotransmitter, glutamate, is closely linked to that of ammonia, it has been postulated that hyperammonemia lowers the availability of the neurotransmitter glutamate. To study this hypothesis, we used brain dialysis to measure glutamate levels in extracellular cerebral fluid from rabbits with acute ischemic liver failure or acute hyperammonemia. The basal glutamate concentration was found to be increased during both acute liver failure (start of experiments 4.9±1.7 μmol/l; end of experiments 9.5±2.1 μmol/l, n=6, difference p<0.05) and acute hyperammonemia (start of experiments 4.4±1.2 μmol/l; end of experiments 7.3±1.8 μmol/l, n=7, difference p>0.05) (mean±SEM). Both the veratridine- and the potassium-evoked glutamate release were increased during acute liver failure but appeared normal during hyperammonemia. We conclude that during acute liver failure and acute hyperammonemia in the rabbit there is no decreased glutamate availability in the extracellular space of the cortical brain; on the contrary, we found evidence for increased extracellular glutamate concentrations in the cortical brain, which were more pronounced in acute liver failure. Experimental hepatic encephalophathy is thus not due to cerebral glutamate deficiency.

0 0
 · 
0 Bookmarks
 · 
11 Views
  • Source
    Article: Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress.
    [show abstract] [hide abstract]
    ABSTRACT: This review addresses recent and not so recent works that emphasize on the mechanisms by which liver damage can induce encephalopathy. Hepatic encephalopathy constitutes an intriguing complication in severe liver acute and chronic disease, whose pathophysiology is still not completely understood. In this pathology, alterations in normal brain function are associated with morphological and functional impairments of astrocytes and neurons. A wide spectrum of psychoneurological symptoms has been described and the anatomical substratum is usually associated with brain edema and intracranial hypertension, as well as with changes in the function of brain cells. An increase in blood ammonia, toxic to the brain, depends on the activity of the enzyme glutamine synthetase, the glutamine/glutamate cycle and the brain capacity to eliminate toxic substances. When the concentration of the excitotoxic neurotransmitter glutamate is increased, it acts as a toxic agent, especially when its specific transporters are altered and its uptake is decreased. Glutamine has also been recently considered a toxic substance when its concentration is high, and consequently contributes to brain edema. Finally, the formation of reactive oxygen species, basically produced by mitochondria, influence with their toxic action on membrane lipids, proteins and DNA. In conclusion we suggest that at least these four elements are involved directly in the mechanism of hepatic encephalopathy.
    Annals of hepatology: official journal of the Mexican Association of Hepatology 8(2):95-102. · 1.81 Impact Factor
  • Source
    Article: Keeping cool in acute liver failure: rationale for the use of mild hypothermia.
    [show abstract] [hide abstract]
    ABSTRACT: Encephalopathy, brain edema and intracranial hypertension are neurological complications responsible for substantial morbidity/mortality in patients with acute liver failure (ALF), where, aside from liver transplantation, there is currently a paucity of effective therapies. Mirroring its cerebro-protective effects in other clinical conditions, the induction of mild hypothermia may provide a potential therapeutic approach to the management of ALF. A solid mechanistic rationale for the use of mild hypothermia is provided by clinical and experimental studies showing its beneficial effects in relation to many of the key factors that determine the development of brain edema and intracranial hypertension in ALF, namely the delivery of ammonia to the brain, the disturbances of brain organic osmolytes and brain extracellular amino acids, cerebro-vascular haemodynamics, brain glucose metabolism, inflammation, subclinical seizure activity and alterations of gene expression. Initial uncontrolled clinical studies of mild hypothermia in patients with ALF suggest that it is an effective, feasible and safe approach. Randomized controlled clinical trials are now needed to adequately assess its efficacy, safety, clinical impact on global outcomes and to provide the guidelines for its use in ALF.
    Journal of Hepatology 01/2006; 43(6):1067-77. · 9.26 Impact Factor
  • Source
    Article: Nutritional support in hepatic encephalopathy.
    [show abstract] [hide abstract]
    ABSTRACT: Hepatic encephalopathy (HE) is a syndrome of global cerebral dysfunction resulting from underlying liver disease or portal-systemic shunting. HE can present as one of four syndromes, depending on the rapidity of onset of hepatic failure and the presence or absence of preexisting liver disease. The precise pathogenesis is unknown but likely involves impaired hepatic detoxification of ammonia as well as alterations in brain transport and metabolism of amino acids and amines. The etiology of malnutrition in hepatic failure is multifactorial. Nutritional deficits may be clinically manifest as marasmus or kwashiorkor, or both. Nutritional support in HE is directed toward reducing morbidity related to underlying malnutrition and concurrent disease. However, reaching nutritional goals is often complicated by protein and carbohydrate intolerance. The use of protein restriction in HE is controversial. Modified formulas that are supplemented in branched chain amino acids may be of value in patients who exhibit protein intolerance with standard feeding solutions or in patients who present with advanced degrees of encephalopathy.
    Nutrition 04/1999; 15(3):220-8. · 3.03 Impact Factor

Keywords

acute hyperammonemia
 
acute ischemic liver failure
 
acute liver failure
 
ammonia toxicity
 
basal glutamate concentration
 
brain dialysis
 
cerebral glutamate deficiency
 
cortical brain
 
decreased glutamate availability
 
excitatory neurotransmitter
 
Experimental hepatic encephalophathy
 
extracellular cerebral fluid
 
extracellular glutamate concentrations
 
hepatic encephalopathy
 
Hyperammonemia
 
measure glutamate levels
 
metabolism
 
neurotransmitter glutamate
 
potassium-evoked glutamate release
 
rabbits